Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Everolimus in Previously Treated Small Cell Lung Cancer
NCT00374140Phase 2Completed
- Sponsor
- Ahmad Tarhini
- Start
- Oct 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in small cell lung cancer (SCLC), sponsored by Ahmad Tarhini. Started Oct 2006; status: completed.
02
Drugs
everolimus
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00374140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374140.